Correlation Between Perk International and Rafarma Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Perk International and Rafarma Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Perk International and Rafarma Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Perk International and Rafarma Pharmaceuticals, you can compare the effects of market volatilities on Perk International and Rafarma Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Perk International with a short position of Rafarma Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Perk International and Rafarma Pharmaceuticals.
Diversification Opportunities for Perk International and Rafarma Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Perk and Rafarma is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Perk International and Rafarma Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rafarma Pharmaceuticals and Perk International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Perk International are associated (or correlated) with Rafarma Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rafarma Pharmaceuticals has no effect on the direction of Perk International i.e., Perk International and Rafarma Pharmaceuticals go up and down completely randomly.
Pair Corralation between Perk International and Rafarma Pharmaceuticals
Given the investment horizon of 90 days Perk International is expected to under-perform the Rafarma Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, Perk International is 1.6 times less risky than Rafarma Pharmaceuticals. The pink sheet trades about -0.04 of its potential returns per unit of risk. The Rafarma Pharmaceuticals is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 68.00 in Rafarma Pharmaceuticals on September 2, 2024 and sell it today you would lose (59.30) from holding Rafarma Pharmaceuticals or give up 87.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Perk International vs. Rafarma Pharmaceuticals
Performance |
| Timeline |
| Perk International |
| Rafarma Pharmaceuticals |
Perk International and Rafarma Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Perk International and Rafarma Pharmaceuticals
The main advantage of trading using opposite Perk International and Rafarma Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Perk International position performs unexpectedly, Rafarma Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rafarma Pharmaceuticals will offset losses from the drop in Rafarma Pharmaceuticals' long position.| Perk International vs. National Health Scan | Perk International vs. RCABS Inc | Perk International vs. Umbra Applied Technologies | Perk International vs. Hitachi Ltd ADR |
| Rafarma Pharmaceuticals vs. Holloman Energy Corp | Rafarma Pharmaceuticals vs. cbdMD Inc | Rafarma Pharmaceuticals vs. Evolus Inc | Rafarma Pharmaceuticals vs. CV Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |